| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 460,1 k € | -1.4% | 466,5 k € | +3.2% | 452,2 k € | +28.4% | 352,3 k € | +12.2% | 314,0 k € | -0.6% | 315,8 k € | +6.1% | 297,6 k € | +3.1% | 288,7 k € | +0.1% | 288,3 k € | +7.9% | 267,2 k € | -14.7% | 313,2 k € | +1.6% | 308,4 k € | +47.4% | 209,3 k € | +42.1% | 147,3 k € | |
| EBITDA | 460,0 k € | -1.2% | 465,6 k € | +3.3% | 450,9 k € | +32.9% | 339,2 k € | +11.8% | 303,3 k € | +0.6% | 301,5 k € | +7.1% | 281,6 k € | +2.8% | 273,9 k € | +0.8% | 271,7 k € | +5.7% | 257,0 k € | -17.7% | 312,1 k € | +1.3% | 308,0 k € | +47.5% | 208,9 k € | +42.6% | 146,5 k € | |
| Operating profit | 456,5 k € | -1.3% | 462,6 k € | +2.8% | 450,2 k € | +32.8% | 339,1 k € | +11.9% | 303,0 k € | +0.6% | 301,2 k € | +7.1% | 281,3 k € | +2.9% | 273,5 k € | +0.8% | 271,2 k € | +5.8% | 256,4 k € | -17.7% | 311,4 k € | +2.4% | 304,1 k € | +47.7% | 206,0 k € | +46.7% | 140,4 k € | |
| Profit/loss | 341,7 k € | +0.0% | 341,5 k € | +5.0% | 325,3 k € | +27.6% | 254,8 k € | +12.7% | 226,2 k € | +8.6% | 208,4 k € | +8.5% | 192,0 k € | +14.9% | 167,1 k € | +2.5% | 163,1 k € | +8.7% | 150,0 k € | -22.1% | 192,5 k € | -4.5% | 201,5 k € | +47.0% | 137,1 k € | +42.0% | 96,5 k € | |
| Equity | 1,7 M € | +24.9% | 1,4 M € | +12.3% | 1,2 M € | +14.8% | 1,1 M € | +9.4% | 968,6 k € | -6.0% | 1,0 M € | +17.0% | 880,4 k € | +27.7% | 689,2 k € | +32.0% | 522,1 k € | +45.4% | 359,0 k € | +71.8% | 209,0 k € | -3.5% | 216,6 k € | +42.4% | 152,1 k € | +39.6% | 108,9 k € | |
| Total assets | 1,8 M € | +9.9% | 1,6 M € | +9.4% | 1,5 M € | +13.1% | 1,3 M € | -0.2% | 1,3 M € | +14.2% | 1,2 M € | +22.9% | 938,0 k € | +26.8% | 740,0 k € | +26.7% | 584,2 k € | +21.6% | 480,5 k € | +18.6% | 405,0 k € | +10.9% | 365,2 k € | +61.4% | 226,3 k € | +39.3% | 162,5 k € | |
| Cash | 228,0 k € | +103.8% | 111,9 k € | -34.0% | 169,6 k € | -45.4% | 310,5 k € | +176.4% | 112,3 k € | -86.0% | 801,1 k € | +26.6% | 632,9 k € | +31.0% | 483,1 k € | +44.5% | 334,2 k € | -30.4% | 480,0 k € | +18.8% | 404,0 k € | +12.0% | 360,6 k € | +70.3% | 211,7 k € | +100.0% | 105,8 k € | |
| Debts | 80,8 k € | -68.9% | 260,2 k € | -3.5% | 269,7 k € | +5.9% | 254,7 k € | -26.8% | 347,8 k € | +184.8% | 122,1 k € | +112.8% | 57,4 k € | +13.0% | 50,8 k € | -14.8% | 59,6 k € | -47.2% | 113,0 k € | -40.4% | 189,4 k € | +28.1% | 147,8 k € | +99.4% | 74,2 k € | +39.8% | 53,1 k € | |
| Staff | — | — | — | — | — | — | — | — | — | 0,3 | — | — | — | — | ||||||||||||||
Private limited company · Oostkamp · incorporated on 27/10/2010
Private limited company profitable and well capitalised. Cash position rising (+103.8%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
DR.SYLVIE VERMEIRE NEFROLOGIE is a Private limited company incorporated in 2010. Its registered office is in Oostkamp.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette